Trials / Completed
CompletedNCT00537615
An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers
A Phase 1 Open-Label Single-Radiolabeled Dose Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0332334 In Six Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the absorption, metabolism and excretion of \[14C\] PD 0332334 to characterize plasma, fecal and urinary radioactivity and identify any metabolites of \[14C\] PD 0332334.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PD 0332334 |
Timeline
- Start date
- 2007-09-01
- Completion
- 2007-10-01
- First posted
- 2007-10-01
- Last updated
- 2010-02-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00537615. Inclusion in this directory is not an endorsement.